Benzofury may refer to:
 | This disambiguation page lists articles associated with the title Benzofury. If an internal link led you here, you may wish to change the link to point directly to the intended article. |
Benzofury may refer to:
| | This disambiguation page lists articles associated with the title Benzofury. If an internal link led you here, you may wish to change the link to point directly to the intended article. |
USS Dorchester (APB-46), was a Benewah-class barracks ship. Her hull classification symbol was initially to be LST-1112. She was first redesignated a General Stores Issue Ship (AKS-17) on 8 December 1944, then as a Self-propelled Barracks Ship (APB-46). Her keel was laid down by Missouri Valley Bridge and Iron Company of Evansville, Indiana. She was launched on 12 April 1945 sponsored by Mrs. J.A. Walsh, and commissioned on 15 June 1945, Lieutenant W.T. Roberts, Jr., USNR, in command.
Heineken Asia Pacific, formerly Asia Pacific Breweries (APB) is an Asian brewery company founded as Malayan Breweries Limited (MBL) in 1931, in a joint venture between Heineken International and Fraser and Neave, it was renamed Asia Pacific Breweries (APB) in 1989 and given its present name after merging with Heineken Asia Pacific in 2013.
APB: All Points Bulletin is an open world multiplayer online video game for Microsoft Windows developed by Realtime Worlds and acquired by Reloaded Productions, which is part of the GamersFirst company. Little Orbit acquired GamersFirst in 2018 and is now in charge of the game's development. Based in urban sprawls and featuring two factions, Enforcers and the Criminals, players can form sub-groups in either faction and carry out missions. The game design was led by David Jones. It was released in 2010 in North America and Europe.
2-Aminoethoxydiphenyl borate (2-APB) is a chemical that acts to inhibit both IP3 receptors and TRP channels (although it activates TRPV1, TRPV2, & TRPV3 at higher concentrations). In research it is used to manipulate intracellular release of calcium ions (Ca2+) and modify TRP channel activity, although the lack of specific effects make it less than ideal under some circumstances. Additionally, there is evidence that 2-APB acts directly to inhibit gap junctions made of connexin. Increasing evidence showed that 2-APB is a powerful modifier of store-operated calcium channels (SOC) function, low concentration of 2-APB can enhance SOC while high concentration induces a transient increase followed by complete inhibition.
6-Br-APB is a synthetic compound that acts as a selective D1 agonist, with the (R)-enantiomer being a potent full agonist, while the (S) enantiomer retains its D1 selectivity but is a weak partial agonist. (R)-6-Br-APB and similar D1-selective full agonists like SKF-81,297 and SKF-82,958 produce characteristic anorectic effects, stereotyped behaviour and self-administration in animals, with a similar but not identical profile to that of dopaminergic stimulants such as amphetamine.
6-(2-Aminopropyl)-2,3-dihydrobenzofuran is a stimulant and entactogen drug of the phenethylamine and amphetamine classes. It is an analogue of MDA where the heterocyclic 4-position oxygen from the 3,4-methylenedioxy ring has been replaced with a methylene bridge. 5-APDB (3-Desoxy-MDA) is an analogue of 6-APDB where the 3-position oxygen has been replaced with a methylene instead. 6-APDB, along with 5-APDB, was first synthesized by David E. Nichols in the early 1990s while investigating non-neurotoxic MDMA analogues.
6-APB is an empathogenic psychoactive compound of the substituted benzofuran, substituted amphetamine and substituted phenethylamine classes. 6-APB and other compounds are sometimes informally called "Benzofury" in newspaper reports. It is similar in structure to MDA, but differs in that the 3,4-methylenedioxyphenyl ring system has been replaced with a benzofuran ring. 6-APB is also the unsaturated benzofuran derivative of 6-APDB. It may appear as a tan grainy powder. While the drug never became particularly popular, it briefly entered the rave and underground clubbing scene in the UK before its sale and import were banned. It falls under the category of research chemicals, sometimes called "legal highs." Because 6-APB and other substituted benzofurans have not been explicitly outlawed in some countries, they are often technically legal, contributing to their popularity.
5-APB is an empathogenic psychoactive compound of the substituted benzofuran, substituted amphetamine and substituted phenethylamine classes. 5-APB and other compounds are sometimes informally called "Benzofury".
A temporary class drug is a relatively new status for controlled drugs, which has been adopted in some jurisdictions, notably New Zealand and the United Kingdom, to attempt to bring newly synthesised designer drugs under legal control. The controlled drug legislation in these jurisdictions requires drug scheduling decisions to follow an evidence-based process, where the harms of the drug are assessed and reviewed so that an appropriate legal status can be assigned. Since many designer drugs sold in recent years have had little or no published research that could help inform such a decision, they have been widely sold as "legal highs", often for months, before sufficient evidence accumulates to justify placing them on the controlled drug schedules.
5-MAPB is an entactogenic designer drug similar to MDMA in its structure and effects.
5-EAPB is an entactogenic amphetamine which is structurally related to 5-MAPB and 5-APB. It might be predicted to show similar effects to these drugs in humans, but the pharmacology of 5-EAPB remains unstudied as of 2013.
6-MAPB is a psychedelic and entactogenic drug which is structurally related to 6-APB and MDMA. It is not known to have been widely sold as a "designer drug" but has been detected in analytical samples taken from individuals hospitalised after using drug combinations that included other benzofuran derivatives. 6-MAPB was banned in the UK in June 2013, along with 9 other related compounds which were thought to produce similar effects.
5-MAPDB (1-(2,3-dihydrobenzofuran-5-yl)-N-methylpropan-2-amine) is a chemical compound which acts as an entactogenic drug. It is structurally related to drugs like 5-APDB and 5-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 5-MAPDB has been studied to determine its pharmacological activity, and was found to be a relatively selective serotonin releaser, though with weaker actions as a releaser of other monoamines and 5-HT2 receptor family agonist, similar to older compounds such as 5-APDB.
6-MAPDB is a chemical compound which might be an entactogenic drug. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser.
6-EAPB is a psychedelic and entactogenic drug of the benzofuran class; it is structurally related to 6-APB and MDMA.
USS Blackford (APB-45) was a Benewah-class self-propelled barracks ship that was in service with the United States Navy during the waning days of World War II. She was decommissioned in April 1947 and sold for merchant service. In c. 1968-1970, she was sunk as a target by the South African Military.
USS Kingman (APB-47) was a self-propelled barracks ship in service with the United States Navy during World War II, and briefly post-war. Laid down as LST-1113, she was then reclassified AKS-18 and named Kingman on 8 December 1944. She was then again reclassified APB-47 on 3 March 1945, and launched on 17 April 1945 by Missouri Valley Bridge & Iron Co., sponsored by Mrs. K. B. Bragg. Kingman shortly after, sailed to be fitted out in New Orleans, Louisiana, and commissioned on 27 June 1945, with Lt. R. J. Figaro in command.
APB is an American procedural drama that aired on Fox from February 6, to April 24, 2017. A first trailer was released on May 16, 2016.
5-MBPB is an entactogenic amphetamine derivative which is structurally related to MDMA and has been sold as a designer drug. It can be described as the benzofuran-5-yl analogue of MBDB or the butanamine homologue of 5-MAPB, and is also a structural isomer of 5-EAPB and 6-EAPB. Anecdotal reports suggest this compound has been sold as a designer drug in various European countries since early 2015, but the first definitive identification was made in December 2015 by a forensic laboratory in Slovenia.